Compounding/Track And Trace Bill Another Victim Of Shutdown
This article was originally published in The Pink Sheet Daily
Executive Summary
The stripped down version will generate considerably less user fee revenue for FDA, but so far it has met the same fate in the Senate as other recent legislation coming from the House.